What is Evolent Health Inc (EVH) stock price today?

Evolent Health Inc (EVH) currently trades at $3.75 per share. The stock has a market capitalization of $349.43M and a P/E ratio of —x.

Is EVH stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Evolent Health Inc has a Smart Value Score of 44/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is 0.03.

What is Evolent Health Inc's revenue and earnings?

Evolent Health Inc has trailing twelve-month (TTM) revenue of $1.88B with profit margins of -28.50%. Earnings per share (EPS) is $-5.07.

Is Evolent Health Inc financially healthy?

Evolent Health Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of 0.03 places it in the distress.

EVH

Evolent Health Inc

NYSE: EVH · HEALTHCARE · HEALTH INFORMATION SERVICES

$3.75

-1.06% today

Updated 2026-04-30

Market cap

$349.43M

P/E ratio

—

P/S ratio

0.19x

EPS (TTM)

$-5.07

Dividend yield

—

52W range

$2 – $12

Volume

3.2M

Market cap

$349.43M

P/E ratio

—

P/S ratio

0.19x

EPS (TTM)

$-5.07

Dividend yield

—

52W range

$2 – $12

Volume

3.2M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

4.7

Growth

3.5

Quality

2.0

Profitability

4.7

Valuation

3/9

Piotroski F-Score

Weak

0.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$5.18

+38.13%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

4 Strong Buy10 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $41.04M — positive

Risks

- Piotroski 3/9 — weak financial health

- Altman Z 0.03 — distress zone

- Thin margins at -28.50%

- Revenue declining -27.50% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$1.35B	$1.96B	$2.55B	$1.88B	$1.88B
Net income	$-19.16M	$-113.04M	$-61.62M	$-534.51M	$-429.13M
EPS	—	—	—	—	$-5.07
Free cash flow	$-49.91M	$113.84M	$-6.13M	$4.75M	$41.04M
Profit margin	-1.42%	-5.76%	-2.41%	-28.49%	-28.50%

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-03	WEINBERG, JONATHAN	Sale	8,275	$3.51
2026-03-03	SHAMS, AAMMAAD	Sale	4,311	$3.51
2026-03-03	MCCARTHY, DANIEL JOSEPH	Sale	24,027	$3.51

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
EVH	$349.43M	44	4.7	2.0	4.7	3.5	—	Hold
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Evolent Health Inc trades at $3.75. Our Smart Value Score of 44/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 0.03, it sits in the distress. TTM revenue stands at $1.88B. with profit margins at -28.50%.

Frequently asked questions

What is Evolent Health Inc's stock price?

Evolent Health Inc (EVH) trades at $3.75.

Is Evolent Health Inc overvalued?

Smart Value Score 44/100 (Grade D, Sell).

What is the price target of Evolent Health Inc (EVH)?

The analyst target price is $5.18, representing +38.1% upside from the current price of $3.75.

What is Evolent Health Inc's revenue?

TTM revenue is $1.88B.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

0.03 — distress.

Company info

SectorHEALTHCARE

IndustryHEALTH INFORMATION SERVICES

CountryUSA

ExchangeNYSE

CurrencyUSD

www.evolent.com

Quick metrics

P/S ratio0.19x

ROE-66.50%

Beta0.37

50D MA$2.79

200D MA$5.73

Shares out0.11B

Float0.09B

Short ratio—

Avg volume3.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

EVH vs LLY →EVH vs JNJ →EVH vs ABBV →Stock screener →